99mTc-Annexin-V uptake in a rat model of variable ischemic severity and reperfusion time

Circulation Journal

Volumn 71, Issue 7, 2007, Pages 1141-1146

  Taki, Junichi ^a   Higuchi, Takahiro ^a   Kawashima, Atsuhiro ^a   Tait, Jonathan F ^b   Muramori, Akira ^a   Matsunari, Ichiro ^c   Nakajima, Kenichi ^a   Vanderheyden, Jean Luc ^d   Strauss, H William ^e  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Medical and Pharmacological Research Center Foundation   (Japan)

^d Theseus Imaging Corporation   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

99mTc Annexin V; Apoptosis imaging; Myocardial ischemia; Reperfusion

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TECHNETIUM LIPOCORTIN 5 TC 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CELL DEGENERATION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG UPTAKE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HISTOLOGY; LEFT CORONARY ARTERY; MALE; NONHUMAN; RAT;

ANIMALS; ANNEXIN A5; APOPTOSIS; AUTORADIOGRAPHY; DISEASE MODELS, ANIMAL; IN SITU NICK-END LABELING; MALE; MYOCYTES, CARDIAC; ORGANOTECHNETIUM COMPOUNDS; RATS; RATS, WISTAR; REPERFUSION INJURY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 34347247614     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1141     Document Type: Article

References (34)

1. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349-6354.
2. 99mTc annexin V. J Nucl Med 1999; 40: 184-191.
3. Blankenberg FG, Tait JF, Strauss HW. Apoptotic cell death: Its implications for imaging in the next millennium. Eur J Nucl Med 2000; 27: 359-367.
4. Strauss HW, Narula J, Blankenberg FG. Radioimaging to identify myocardial cell death and probably injury. Lancet 2000; 356: 180-181.
5. Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for (99m)Tc. Bioconjug Chem 2000; 11: 918-925.
6. Flotats A, Carrio I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging 2003; 30: 615-630.
7. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, et al. Past, present, and future of annexin A5: From protein discovery to clinical applications. J Nucl Med 2005; 46: 2035-2050.
8. Maulik N, Kagan VE, Tyurin VA, Das DK. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol 1998; 274: H242-H248.
9. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-1556.
10. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264: 7944-7949.
11. 99mTc-labeled annexin V. J Nucl Med 2004; 45: 1536-1541.
12. 99mTc-Hynic-annexin V imaging to evaluate inflammation and apoptosis in rats with autoimmune myocarditis. Eur J Nucl Med Mol Imaging 2003; 30: 232-238.
13. (99m)Tc-annexin-V in experimental subacute myocarditis. J Nucl Med 2004; 45: 1081-1086.
14. Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, et al. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998; 116: 844-853.
15. Kown MH, Van der Steenhoven T, Blankenberg FG, Hoyt G, Berry GJ, Tait JF, et al. Zinc-mediated reduction of apoptosis in cardiac allografts. Circulation 2000; 102: III-228-III-232.
16. 99mTc- annexin V. J Nucl Med 2001; 42: 382-387.
17. 99mTc-BTAP-annexin-V in humans. Eur J Nucl Med 2001; 28: 1373-1378.
18. Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000; 356: 209-212.
19. Thimister PWL, Hofstra L, Liem IH, Boersma HH, Kemerink G, Reutelingsperger CP, et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. J Nucl Med 2003; 44: 391-396.
20. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001; 7: 1347-1352.
21. 99mTc-Rh-Annexin V: Results of a multicenter trial (abstract). Circulation 2002; 106(Suppl II): 331.
22. Otani H, Matsuhisa S, Akita Y, Kyoi S, Enoki C, Tatsumi K, et al. Role of mechanical stress in the form of cardiomyocyte death during the early phase of reperfusion. Circ J 2006; 70: 1344-1355.
23. Shao ZQ, Takaji K, Katayama Y, Kunitomo R, Sakaguchi H, Lai ZF, et al. Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ J 2006; 70: 471-477.
24. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996; 79: 949-956.
25. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621-1628.
26. Hammill AK, Uhr JW, Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 1999; 251: 16-21.
27. Furukawa Y, Bangham CR, Taylor GP, Weber JN, Osame M. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Clin Exp Immunol 2000; 120: 307-316.
28. Martin S, Pombo I, Poncet P, David B, Arock M, Blank U. Immunologic stimulation of mast cells leads to the reversible exposure of phosphatidylserine in the absence of apoptosis. Int Arch Allergy Immunol 2000; 123: 249-258.
29. Geske FJ, Lieberman R, Strange R, Gerschenson LE. Early stages of p53-induced apoptosis are reversible. Cell Death Differ 2001; 8: 182-191.
30. Yang MY, Chuang H, Chen RF, Yang KD. Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks. J Leukoc Biol 2002; 71: 231-237.
31. Kenis H, Van Genderen H, Bennaghmouch A, Rinia HA, Frederik P, Narula J, et al. Cell surface expressed phosphatidylserine and Annexin A5 open a novel portal of cell entry. J Biol Chem 2004; 279: 52623-52629.
32. 99mTc-Annexin-V imaging (abstract). J Nucl Med 2000; 41: 173.
33. 99mTc-Annexin-V imaging (abstract). Circulation 2000; 102: II-544.
34. van den Eijnde SM, Luijsterburg AJ, Boshart L, De Zeeuw CI, van Dierendonck JH, Reutelingsperger CP, et al. In situ detection of apoptosis during embryogenesis with annexin V: From whole mount to ultrastructure. Cytometry 1997; 29: 313-320.